In support of improving patient care, these activities have been planned and implemented by the Postgraduate Institute for Medicine and Total CME. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates each live activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates each continuing education activity for 0.5 contact hour (0.05 CEUs) of the Accreditation Council for Pharmacy Education.
- Challenging Cases in Managing Polycythemia Vera - UAN: JA4008162-9999-22-101-L01-P; 0.5 contact hour; Knowledge
- Challenging Cases in Managing Myelofibrosis- UAN: JA4008162-9999-22-005-L01-P; 0.5 contact hour; Knowledge
- Challenging Cases in Managing Essential Thrombocythemia - UAN: JA4008162-9999-22-011-L01-P; 0.5 contact hour; Knowledge
: You are not eligible to receive ACPE credit if you have previously attended and received credit for any of the above listed activities.
Continuing Nursing Education
The maximum number of hours awarded for each Continuing Nursing Education activity is 0.5 contact hour.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
These activities have been designed to meet the educational needs of physicians, registered nurses, pharmacists and other healthcare professionals involved in the care of patients with myeloproliferative neoplasms (MPNs).
There is no fee for these educational activities.
Jointly provided by Postgraduate Institute for Medicine and Total CME
These activities are supported by an independent educational grant from Incyte Corporation